A series of studies have shown that high levels of IGF‐1 are associated with an increased risk of tumors including prostate, pre‐ and postmenopausal breast, lung, thyroid, and colorectal cancers (Ma et al., 1999; Renehan et al., 2004; Shi et al., 2001). The gene discussed is IGF1; the disease is colorectal cancer.